The IBM's Watson super-brainy computing technology, which has helped in managing massive data and has defeated champions on the Jeopardy TV show, is now learning Japanese. The move has been taken to share Watson with startups and universities for a variety of consumer applications, starting October.

Senior Vice President of Watson Mike Rhodin told reporters that Watson has proven to be an effective tool in handling a large amount of unstructured data, such as clinical tests, information on drugs and regulations in the legal field. He added that Watson can also help teachers.

IBM is also teaming up with CVS Health to harness the power of the Watson supercomputing brain to bring radical changes in how the care of patients with chronic conditions is managed.

Both the companies under a deal expected to be signed on Thursday will work together to develop a system that provides better personalized care, and prevent the use of unneeded and costly interventions.

The new system will also be able to predict health declines for a wide range of conditions including heart disease, diabetes and obesity.

Troyen A. Brennan, chief medical officer for CVS Health, said in an interview that no specific product or timeline has been worked out so far. But he said that in the first stage they would jointly develop intelligent algorithms and test them to see if they helped improve patient outcomes.

Brennan said, "When you go into a cognitive computing approach like this you're not sure what you're going to turn up. We're at the point of scientific discovery, not productization".

He added that the main aim behind making these types of systems work is to open lines of communication between a pharmacist, clinic staff and a patient's physician and that technology can help facilitate this dialogue.